Complement activation fragment Bb in early pregnancy and spontaneous preterm birth

Gibbs, 2001, The relationship between infections and adverse pregnancy outcomes: An overview, Ann Periodontol, 6, 153, 10.1902/annals.2001.6.1.153 Goldenberg, 2000, Intrauterine infection and preterm delivery, N Engl J Med, 342, 1500, 10.1056/NEJM200005183422007 Goldenberg, 2008, Epidemiology and causes of preterm birth, Lancet, 371, 75, 10.1016/S0140-6736(08)60074-4 Buekens, 2001, Preterm birth research: From disillusion to the search for new mechanisms, Paediatr Perinat Epidemiol, 15, 159, 10.1046/j.1365-3016.2001.00015.x Green, 2005, Research agenda for preterm birth: Recommendations from the March of Dimes, Am J Obstet Gynecol, 193, 626, 10.1016/j.ajog.2005.02.106 Hamilton, 2006, Births: Preliminary data for 2005, Natl Vital Stat Rep, 55, 1 Hillier, 1988, A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity, N Engl J Med, 319, 972, 10.1056/NEJM198810133191503 Romero, 2007, The role of inflammation and infection in preterm birth, Semin Reprod Med, 25, 21, 10.1055/s-2006-956773 Romero, 2002, Infection and prematurity and the role of preventive strategies, Semin Neonatol, 7, 259, 10.1053/siny.2002.0121 Lockwood, 2002, Predicting premature delivery—no easy task, N Engl J Med, 346, 282, 10.1056/NEJM200201243460412 Watts, 1992, The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor, Obstet Gynecol, 79, 351, 10.1097/00006250-199203000-00005 Cassell, 1983, Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy, Sex Transm Dis, 10, 294 Horowitz, 1995, Infection of the amniotic cavity with Ureaplasma urealyticum in the midtrimester of pregnancy, J Reprod Med, 40, 375 Ghidini, 2005, Histologic placental lesions in women with recurrent preterm delivery, Acta Obstet Gynecol Scand, 84, 547, 10.1111/j.0001-6349.2005.00694.x Goldenberg, 2000, The preterm prediction study: Granulocyte colony-stimulating factor and spontaneous preterm birth, Am J Obstet Gynecol, 182, 625, 10.1067/mob.2000.104210 Caucheteux, 2003, At the innate frontiers between mother and fetus: Linking abortion with complement activation, Immunity, 18, 169, 10.1016/S1074-7613(03)00028-1 Gibbs, 2002, Chronic intrauterine infection and inflammation in the preterm rabbit, despite antibiotic therapy, Am J Obstet Gynecol, 186, 234, 10.1067/mob.2002.119640 Bordet, 1901, Sur l'existences de substance sensibilisatrices dans la plupart des serum antimicrobiens, Ann Inst Pasteur, 15, 289 Thurman, 2006, The central role of the alternative complement pathway in human disease, J Immunol, 176, 1305, 10.4049/jimmunol.176.3.1305 Salmon, 2002, Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis, Ann Rheum Dis, 61, ii46, 10.1136/ard.61.suppl_2.ii46 Holers, 2002, Complement C3 activation is required for antiphospholipid antibody-induced fetal loss, J Exp Med, 195, 211, 10.1084/jem.200116116 Lynch, 2008, Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia, Am J Obstet Gynecol, 198, 385e1, 10.1016/j.ajog.2007.10.793 Janeway, 2005 Holers, 2001, Complement Walport, 2001, Complement, N Engl J Med, 344, 1058, 10.1056/NEJM200104053441406 Markiewski, 2007, The role of complement in inflammatory diseases from behind the scenes into the spotlight, Am J Pathol, 171, 715, 10.2353/ajpath.2007.070166 Zipfel, 2006, Complement and diseases: defective alternative pathway control results in kidney and eye diseases, Mol Immunol, 43, 97, 10.1016/j.molimm.2005.06.015 Elimian, 1998, Amniotic fluid complement C3 as a marker of intra-amniotic infection, Obstet Gynecol, 92, 72, 10.1016/S0029-7844(98)00123-9 Soto, 2005, Anaphylatoxins in preterm and term labor, J Perinat Med, 33, 306, 10.1515/JPM.2005.051 Engle, 2006, A recommendation for the definition of “late preterm” (near-term) and the birth weight-gestational age classification system, Semin Perinatol, 30, 2, 10.1053/j.semperi.2006.01.007 Iams, 2004, Preterm labor and delivery, 623 Raju, 2006, Optimizing care and outcome for late-preterm (near-term) infants: A summary of the workshop sponsored by the National Institute of Child Health and Human Development, Pediatrics, 118, 1207, 10.1542/peds.2006-0018 Lockwood, 2001, Risk stratification and pathological mechanisms in preterm delivery, Paediatr Perinat Epidemiol, 2, 78, 10.1046/j.1365-3016.2001.00010.x Mercer, 2008, Small fetal size before 20 weeks' gestation: Associations with maternal tobacco use, early preterm birth, and low birthweight, Am J Obstet Gynecol, 198, 673.e1, 10.1016/j.ajog.2008.01.036 Edlow, 2007, Second-trimester loss and subsequent pregnancy outcomes: What is the real risk?, Am J Obstet Gynecol, 197, 581.e1, 10.1016/j.ajog.2007.09.016 Walport, 2001, Complement, N Engl J Med, 344, 1140, 10.1056/NEJM200104123441506 Gibbs, 1992, A review of premature birth and subclinical infection, Am J Obstet Gynecol, 166, 1515, 10.1016/0002-9378(92)91628-N Matzinger, 2002, The danger model: A renewed sense of self, Science, 296, 301, 10.1126/science.1071059 Kohl, 2006, The role of complement in danger sensing and transmission, Immunol Res, 34, 157, 10.1385/IR:34:2:157 Hageman, 2005, A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration, Proc Natl Acad Sci U S A, 102, 7227, 10.1073/pnas.0501536102 Gehrs, 2006, Age-related macular degeneration—emerging pathogenetic and therapeutic concepts, Ann Med, 38, 450, 10.1080/07853890600946724 Girardi, 2004, Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation, Nat Med, 10, 1222, 10.1038/nm1121 Holers, 2003, The complement system as a therapeutic target in autoimmunity, Clin Immunol, 107, 140, 10.1016/S1521-6616(03)00034-2 Kirschfink, 2001, Targeting complement in therapy, Immunol Rev, 180, 177, 10.1034/j.1600-065X.2001.1800116.x